Conversely, Djukic [43] reported a statistically significant increase in the risk of developing COVID-19 in individuals with specific GSTO polymorphisms, including the GSTO1 AA, GSTO2 AG, and GSTO2 GG genotypes. This evidence concerns the gene GSTO1 and COVID-19.